Covered recipient · General Payments record
YULIENNY CABRERA JIMENEZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$1,050.19
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $817.58 | 30 |
| Education | $33.80 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $345.59 | 18 |
| Abbott Laboratories | $124.42 | 1 |
| E.R. Squibb & Sons, L.L.C. | $122.90 | 1 |
| Lilly USA, LLC | $57.29 | 3 |
| Novo Nordisk AS | $37.92 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $37.44 | 2 |
| Paratek Pharmaceuticals, Inc. | $24.65 | 1 |
| Noven Therapeutics, LLC | $20.06 | 1 |
| Corium, Inc. | $19.24 | 1 |
| Exact Sciences Corporation | $18.83 | 1 |
| IBSA Pharma Inc. | $14.94 | 1 |
| Amgen Inc. | $14.36 | 1 |
| Renalytix AI, Inc. | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $124.42 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124893011 | CMS |
| ABBVIE INC. | $19.95 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861245 | CMS |
| ABBVIE INC. | $21.65 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861247 | CMS |
| ABBVIE INC. | $27.96 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861249 | CMS |
| ABBVIE INC. | $124.64 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861251 | CMS |
| ABBVIE INC. | $21.65 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861253 | CMS |
| ABBVIE INC. | $11.35 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861255 | CMS |
| ABBVIE INC. | $8.45 | 04/15/2024 | Education | Undisputed | 01/23/2026 | 1106861257 | CMS |
| ABBVIE INC. | $5.09 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861259 | CMS |
| ABBVIE INC. | $8.45 | 04/26/2024 | Education | Undisputed | 01/23/2026 | 1106861261 | CMS |
| ABBVIE INC. | $3.92 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861263 | CMS |
| ABBVIE INC. | $24.31 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861265 | CMS |
| ABBVIE INC. | $8.03 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861267 | CMS |
| ABBVIE INC. | $6.33 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861269 | CMS |
| ABBVIE INC. | $8.45 | 07/03/2024 | Education | Undisputed | 01/23/2026 | 1106861271 | CMS |
| ABBVIE INC. | $8.45 | 07/22/2024 | Education | Undisputed | 01/23/2026 | 1106861273 | CMS |
| ABBVIE INC. | $26.27 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861275 | CMS |
| ABBVIE INC. | $6.15 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861277 | CMS |
| ABBVIE INC. | $4.49 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106861279 | CMS |
| Amgen Inc. | $14.36 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117215390 | CMS |
| Corium, LLC | $19.24 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100100368 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.90 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101201198 | CMS |
| Exact Sciences Corporation | $18.83 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114604642 | CMS |
| IBSA Pharma Inc. | $14.94 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142978200 | CMS |
| Lilly USA, LLC | $17.98 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135987534 | CMS |
| Lilly USA, LLC | $24.44 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135987944 | CMS |
| Lilly USA, LLC | $14.87 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135972034 | CMS |
| Novartis Pharmaceuticals Corporation | $17.57 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086775395 | CMS |
| Novartis Pharmaceuticals Corporation | $19.87 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086775381 | CMS |
| Noven Therapeutics, LLC | $20.06 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084839843 | CMS |
| Novo Nordisk Inc | $17.02 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100341236 | CMS |
| Novo Nordisk Inc | $20.90 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100224466 | CMS |
| Paratek Pharmaceuticals, Inc. | $24.65 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113925956 | CMS |
| Renalytix AI, Inc. | $13.74 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116760480 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.